. Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia. Neurobiol Aging. 2008 Aug;29(8):1143-59. Epub 2007 Apr 10 PubMed.

AlzBiomarker Database

Meta-Analysis

Curated Study Data

Biomarker
(Source)
Cohort
(N)
Measurement
Mean ± SD
Method;
Assay Name;
Manufacturer
Diagnostic
Criteria
Aβ42
(CSF)
AD
(51)
353 ± 140
pg/mL
ELISA;
Innotest;
Innogenetics
Aβ42
(CSF)
CTRL-
Other Controls
(97)
699 ± 155
pg/mL
ELISA;
Innotest;
Innogenetics
tau-p181
(CSF)
AD
(51)
68.1 ± 26
pg/mL
ELISA;
Innotest;
Innogenetics
tau-p181
(CSF)
CTRL-
Other Controls
(97)
40.9 ± 15.5
pg/mL
ELISA;
Innotest;
Innogenetics
tau-total
(CSF)
AD
(51)
560 ± 284
pg/mL
ELISA;
Innotest;
Innogenetics
tau-total
(CSF)
CTRL-
Other Controls
(97)
231 ± 149
pg/mL
ELISA;
Innotest;
Innogenetics

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

AlzAntibodiesAlzBiomarkerAlzRiskBrain BanksGeneticsAlzGeneHEXMutationsProtocolsResearch ModelsTherapeutics